Picture of Glanbia logo

GL9 Glanbia Share Price

0.000.00%
ie flag iconLast trade - 00:00
Consumer DefensivesBalancedLarge CapHigh Flyer

Momentum

Relative Strength (%)
1m-2.27%
3m+10.79%
6m+12.51%
1yr+27.34%
Volume Change (%)
10d/3m+4.41%
Price vs... (%)
52w High-5.02%
50d MA+3.32%
200d MA+13.3%

Growth & Value

12m Forecast RollingIndustryMarket
PE Ratio (f)13.64
PEG Ratio (f)0.96
EPS Growth (f)16.53%
Dividend Yield (f)2.2%
Valuation (ttm)IndustryMarket
Price to Book Value2.32
Price to Tang. Book8.3
Price to Free Cashflow13.96
Price to Sales0.91
EV to EBITDA9.8

Shareholder Activity

TypeBuy / Hold / Sell
Institutions
Directors
Community

Guru Screens

Quality

NameIndustryMarket
Return on Capital13.44%
Return on Equity16.88%
Operating Margin7.23%

Financial Summary

Year End 30th DecUnit201920202021202220232024E2025ECAGR / Avg
Total Revenue$m4,336.524,359.394,960.435,943.75,425.44,432.214,472.77.72%
Operating Profitm
Net Profitm
EPS Reported
Diluted Normalised EPS
EPS Growth%-8.5-23.98+27.19+22.04+10.21+21.12+7.13n/a
PE Ratiox
PEG
Profitability
Operating Margin%
ROA%
ROCE%
ROE%
Cashflow
Op. Cashflow ps
Capex ps
Free Cashflow ps
Dividends
Dividend ps
Dividend Growth%
Dividend Yield%
Dividend Coverx
Balance Sheet
Cash etcm
Working Capitalm
NFAm
Net Debtm
Book Valuem
Diluted Weighted Average Sharesm
Book Value ps

Health Trend(F-Score)

12345678910

Bankruptcy Score(Z-Score)

Distress
Cautious
Safe

Earnings Manipulation Risk(M-Score)

Other Ratios

Leverage (ttm)Total- Intang+ Pension
Gross Gearing
Net Gearing
Cash / Assets

Recent History

Latest interim period vs. prior periodIndustryMarket
Sales Growth
EPS Growth
3yr Compound Annual Growth RateIndustryMarket
Sales CAGR
EPS CAGR
DPS CAGR

Graphical History

Revenue
Blurred out image of Revenue chart
Net Income
Blurred out image of Net Income chart
Normalised EPS
Blurred out image of Normalised EPS chart
PE Ratio Range
Blurred out image of PE Ratio Range chart
Dividend Yield Range
Blurred out image of Dividend Yield Range chart

Analyst Forecasts

Price target
( price)
30th Dec 202430th Dec 2025
Est. Long Term Growth Rate: Net Profit
()
EPS
()
DPS
()
Net Profit
()
EPS
()
DPS
()
Consensus Estimate
1m Change
3m Change

Analyst Consensus

Strong SellSellHoldBuyStrong Buy

EPS 2024 / 2025

Blurred out image of Glanbia EPS forecast chart

Profile Summary

Glanbia plc is an Ireland-based nutrition company. The Company’s segments include Glanbia Performance Nutrition and Glanbia Nutritionals. The Glanbia Performance Nutrition segment manufactures and sells sports nutrition and lifestyle nutrition products through a variety of channels including specialty retail, online, Food, Drug, Mass, Club (FDMC), and gyms in a variety of formats, including powders, ready-to-eat (bars and snacking foods) and ready-to-drink beverages. The Glanbia Nutritionals segment manufactures and sells cheese, dairy and non-dairy nutritional and functional ingredients, and vitamin and mineral premixes targeting the increased market focus on health and nutrition. Its subsidiaries include Alanfield Society Limited, Glanbia Finance International Designated Activity Company, Glanbia Financial Services Unlimited Company, Glanbia GNPN Holding Limited, Glanbia Holdfin Limited, and Glanbia Investchip Limited.

Directors

Last Annual
December 30th, 2023
Last Interim
December 30th, 2023
Incorporated
March 10th, 1988
Public Since
March 1st, 1988
No. of Employees
5,534
Sector
Food & Tobacco
Industry
Consumer Defensives
Exchange
ie flag iconIrish Stock Exchange
Shares in Issue
263,783,250

GL9 Share Price Performance

Upcoming Events for GL9

Q1 2024 Glanbia PLC Interim Management Statement Release

Glanbia PLC Annual Shareholders Meeting

Glanbia PLC Annual Shareholders Meeting

Half Year 2024 Glanbia PLC Earnings Release

Similar to GL9

Picture of Donegal Investment logo

Donegal Investment

ie flag iconIrish Stock Exchange

Picture of Kerry logo

Kerry

ie flag iconIrish Stock Exchange

Picture of Origin Enterprises logo

Origin Enterprises

ie flag iconIrish Stock Exchange

FAQ